A Study of IBI306 in Participants With Hypercholesterolemia

NCT04709536 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

306

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: IBI306
DRUG: Placebo

Sponsor

Innovent Biologics (Suzhou) Co. Ltd.